共 50 条
- [44] Investigation of Cardiovascular Disease and Metabolic Syndrome Risk with Copeptin in Psoriasis Patients: A Case-Control Study HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2022, 60 (03): : 270 - 275
- [47] Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study European Journal of Dermatology, 2014, 24 : 662 - 669
- [49] Concomitant Sleep Disorders Significantly Increase the Risk of Cardiovascular Disease in Patients with Psoriasis PLOS ONE, 2016, 11 (01):